These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31122739)

  • 1. Mapping and definition of HLA class I and II serologic epitopes using an unbiased reverse engineering strategy.
    Yamamoto F; Wang L; Chang CJ; Tyan DB
    Hum Immunol; 2019 Sep; 80(9):668-702. PubMed ID: 31122739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reverse-engineering strategy utilizing the integration of single antigen beads and NGS HLA genotypes to detect potential antibody inducing epitopes.
    Chang CJ; Yamamoto F; Tyan DB
    Hum Immunol; 2019 Sep; 80(9):661-667. PubMed ID: 30978444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
    Creary LE; Guerra SG; Chong W; Brown CJ; Turner TR; Robinson J; Bultitude WP; Mayor NP; Marsh SGE; Saito K; Lam K; Duke JL; Mosbruger TL; Ferriola D; Monos D; Willis A; Askar M; Fischer G; Saw CL; Ragoussis J; Petrek M; Serra-Pagés C; Juan M; Stavropoulos-Giokas C; Dinou A; Ameen R; Al Shemmari S; Spierings E; Gendzekhadze K; Morris GP; Zhang Q; Kashi Z; Hsu S; Gangavarapu S; Mallempati KC; Yamamoto F; Osoegawa K; Vayntrub T; Chang CJ; Hansen JA; Fernández-Viňa MA
    Hum Immunol; 2019 Jul; 80(7):449-460. PubMed ID: 30844424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
    Papassavas AC; Barnardo MC; Bunce M; Welsh KI
    Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should epitope-based HLA compatibility be used in the kidney allocation system?
    Duquesnoy RJ
    Hum Immunol; 2017 Jan; 78(1):24-29. PubMed ID: 27771385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
    Mitić NS; Pavlović MD; Jandrlić DR
    J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation.
    Laux G; Mytilineos J; Opelz G
    Transplantation; 2004 Mar; 77(6):902-7. PubMed ID: 15077035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method.
    Gutiérrez AH; Martin WD; Bailey-Kellogg C; Terry F; Moise L; De Groot AS
    BMC Bioinformatics; 2015 Sep; 16():290. PubMed ID: 26370412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the identification of the relative immunogenicity of individual HLA antibody epitopes.
    Kramer C; Heidt S; Claas FHJ
    Hum Immunol; 2019 Apr; 80(4):218-220. PubMed ID: 30735757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-EMMA: A user-friendly tool to analyse HLA class I and class II compatibility on the amino acid level.
    Kramer CSM; Koster J; Haasnoot GW; Roelen DL; Claas FHJ; Heidt S
    HLA; 2020 Jul; 96(1):43-51. PubMed ID: 32227681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation.
    Tran JN; Günther OP; Sherwood KR; Fenninger F; Allan LL; Lan J; Sapir-Pichhadze R; Duquesnoy R; Claas F; Marsh SGE; McMaster WR; Keown PA;
    Commun Biol; 2021 May; 4(1):583. PubMed ID: 33990681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II DP epitopes.
    Deng CT; Cai J; Ozawa M; El-Awar N
    Clin Transpl; 2007; ():195-202. PubMed ID: 18637470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report on the antibody verification of MICA epitopes recorded in the HLA epitope registry.
    Duquesnoy RJ; Mostecki J; Marrari M; da Silva AS; da Mata Sousa LC; do Monte SJ
    Int J Immunogenet; 2014 Oct; 41(5):370-7. PubMed ID: 25053277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
    Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
    Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
    Marrari M; Duquesnoy RJ
    Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terasaki Epitope Mismatch Burden Predicts the Development of De Novo DQ Donor-Specific Antibodies and are Associated With Adverse Allograft Outcomes.
    Willicombe M; Blow M; Santos-Nunez E; Freeman C; Brookes P; Taube D
    Transplantation; 2018 Jan; 102(1):127-134. PubMed ID: 28731902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.